IMAGE ANALYSIS GROUP (IAG)

IAG, Image Analysis Group is comprised of Image Analysis, Ltd. (London, UK), Image Analysis, Inc. (Philadelphia, PA, USA) and Venture Partners. IAG is unique partner to life sciences companies. Our goal is to accelerate novel drug development by using the right analytical tools and modern trial infrastructure.We bring AI, Machine Learning and smart image analysis methods to ensure the speed and cost-effectiveness, while delivering true insights about your mechanism of action and patients’ response, in real-time.We leverage our core expertise in medical image analysis, drug development and trial design.Through quantitative imaging-based assessments, we help our biotech and pharma clients to understand the specifics of their therapeutic agents.We work with investors and executive teams on deploying the right strategies for early efficacy assessments, objective response prediction and critical analysis of advanced treatment manifestations (such as pseudo-progression in immuno-oncology).Thus, lowering the investment risks into advanced therapies while helping to accelerate study outcomes.IAG brings decades of operational expertise, proprietary platform DYNAMIKA and deep therapeutic insights through our world-class expert team.We have entrepreneurial mindset agile culture and can-do attitude. We are here to create successful partnerships and see more patients cured with the drugs, that we can help you to develop.